ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,316Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 178

$469K Total Retail Price of All Prescriptions

Rank: 15 out of 178

335 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in District of Columbia
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 335 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 335 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 5,009 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $77 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in District of Columbia
LISINOPRIL 388 262 1 2
AMLODIPINE BESYLATE 296 230 2 1
FUROSEMIDE 283 217 3 6
SIMVASTATIN 205 155 4 3
HYDROCHLOROTHIAZIDE 187 124 5 5
ATORVASTATIN CALCIUM 187 138 5 4
METFORMIN HCL 143 81 7 7
TRAMADOL HCL 137 87 8 30
METOPROLOL TARTRATE 117 103 9 10
OMEPRAZOLE 117 72 9 9
METOPROLOL SUCCINATE 111 80 11 11
ACETAMINOPHEN-CODEINE 108 46 S3 12 20
GABAPENTIN 107 71 13 14
WARFARIN SODIUM 99 97 14 15
RISPERIDONE 97 93 15 61
POTASSIUM CHLORIDE 94 93 16 43
CLOPIDOGREL 90 78 17 36
ZOLPIDEM TARTRATE 89 59 18 16
DONEPEZIL HCL 89 86 18 29
LYRICA 84 56 20 86
LEVOTHYROXINE SODIUM 81 64 21 8
HYDRALAZINE HCL 76 49 22 24
CLONIDINE HCL 76 12 22 28
OXYCODONE-ACETAMINOPHEN 74 18 S2 24 31
NAMENDA 72 72 25 53
CARVEDILOL 68 38 26 27
NEXIUM 68 44 26 25
ADVAIR DISKUS 66 23 28 46
HYDROCODONE-ACETAMINOPHEN 64 44 S3 29 37
LANTUS 64 25 29 26
FAMOTIDINE 63 53 31 73
SPIRIVA 62 37 32 65
PROAIR HFA 62 19 32 35
JANUVIA 60 45 34 88
COLCRYS 59 40 35 52
PLAVIX 58 54 36 54
PREDNISONE 57 40 37 64
DIOVAN 55 44 38 23
TAMSULOSIN HCL 55 49 38 40
LOSARTAN POTASSIUM 55 38 38 12
BENICAR 53 40 41 92
MIRTAZAPINE 51 44 42 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.